BA/BE Studies India: New Prior Intimation System Cuts 90 Days
CDSCO’s March 2026 reforms introduce prior intimation for BA/BE studies, reducing approval times from 90 to 45 days for faster market access.
CDSCO’s March 2026 reforms introduce prior intimation for BA/BE studies, reducing approval times from 90 to 45 days for faster market access.
New rules effective March 7, 2026 cut approval timelines from 90 to 45 days. Prior intimation replaces licenses for low-risk studies.
Recent searches reveal minimal NDPS notifications in Q1 2026, while related pharmaceutical regulations show active enforcement. Key compliance insights.
CDSCO threatens rejection of 2+ year pending applications by Feb 14, 2026. New IVD import guidance and cosmetic enforcement actions reshape compliance.
Key highlights from the CDSCO circular on “Testing of drugs for grant of permissions for import/manufacture of New Drug for sale or for distribution and
G.S.R. 135(E) – Changes to the Drugs Rules On February 16, 2026, the Central Drugs Standard Control Organization (CDSCO) rolled out Notification G.S.R. 135(E), bringing
Let’s be real: in today’s business world, you can’t just ignore compliance. It’s not a box to tick—it’s something you’ve got to nail if you
Highlights and benefits of the recent U.S.–India trade agreement, with a focus on what it does (including tariff reductions) and why it matters — drawing
India-EU Free Trade Agreement — The “Mother of All Deals” Big news on the trade front: On January 27, 2026, India and the European Union
Noida’s business scene is changing fast, and if you want your products to hit the market without hiccups, you need to meet the Bureau of